A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.
The Food and Drug Administration issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to ...
Over 7,000 bottles of the antidepressant medication duloxetine, sold under the brand name Cymbalta, have been recalled, the ...
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a ...
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National ...
The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of ...
The FDA's recall involves 7,107 bottles containing 500 delayed-release 20 milligram duloxetine capsules, which are prescribed to treat conditions such as anxiety, depression, nerve pain related to ...
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
The Food and Drug Administration has issued a recall for more than 7,000 bottles of an antidepressant drug because of the ...
The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high ...